
Opinion|Videos|May 28, 2024
Utilization of APOE4 Genotype in Management of Alzheimer’s Disease
Medical experts discuss the application of ApoE gene polymorphism and copy number data in managing Alzheimer's disease, highlighting its relevance for individuals with a family history of AD, and symptomatic patients.
Advertisement
Episodes in this series

Video content above is prompted by the following question:
- How are you utilizing ApoE gene polymorphism and copy numbers data to manage AD?
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
CTAD Presentation Lays Insights Into Disappointing Phase 3 EVOKE Trial of GLP-1 Semaglutide in Alzheimer Disease
2
Merck’s Novel Antibody MK-2214 Receives FDA Fast-Track Designation Following Phase 1 Results
3
Analyzing Subgroup Data From the TRAILBLAZER-ALZ 2 Study of Donanemab: Brandy Matthews, MD
4
Dravet Syndrome Medication Stiripentol Effective in Real World Settings Across Various Patient Profiles
5



































